Michael R. Dufault, n/a

Principal Scientist
Sanofi Corporation

Poster(s):

• Tu223 - Anti-tnf Treatment Response Classifier for Inflammatory Bowel Disease Patients
  Tuesday, June 20, 2023

  6:00 PM – 7:45 PM